Derivatives of 1-arylsulphonyl-1,5-dihydro-2H-pyrrol-2-one, and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548542, C07D20738, D61K 3140

Patent

active

048853070

ABSTRACT:
Compounds useful in the treatment of patients suffering from intellectual or nervous asthenias, memory failures, senescence or mental strain of the formula (I) ##STR1## in which R' represents hydrogen, a linear, branched or cyclic alkyl containing up to 8 carbon atoms, alkenyl containing from 2 to 8 carbon atoms, acyl containing from 1 to 6 carbon atoms or aralkyl containing from 7 to 15 carbon atoms and R represents aryl containing up to 14 carbon atoms, possibly substituted, or a mono- or polycyclic heterocyclic aromatic radical, possibly substituted; also thereapeutic compositions containing those compounds and method of use.

REFERENCES:
patent: 3117975 (1964-01-01), Bortnick et al.
patent: 3423426 (1969-01-01), Kohn
patent: 3686169 (1972-08-01), Coran et al.
Drugs of the Future, vol. 10, No. 12, 1985, pp. 972, 974.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Derivatives of 1-arylsulphonyl-1,5-dihydro-2H-pyrrol-2-one, and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives of 1-arylsulphonyl-1,5-dihydro-2H-pyrrol-2-one, and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 1-arylsulphonyl-1,5-dihydro-2H-pyrrol-2-one, and will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2034699

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.